Pharma stock engaged in manufacturing and distributing of pharmaceutical products gained traction on Thursday’s trading ...

The guacamole, peppers, and vegetables voluntarily recalled by the maker have been classed as the highest risk level by the ...

Share Market Updates - Find here all the updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets ...

The approved ANDA is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR extended-release tablets in strength of ...

Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.

The clearance from the US FDA opens the doors for Shivalik Rasayan to file new products for the facility, aimed at exporting ...

The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.

Patients with metastatic castration-sensitive prostate cancer are recommended to be treated with enzalutamide tablets.

This approval adds to Alembic Pharma's growing portfolio, which now includes 216 ANDA approvals from the USFDA, comprising ...

Additionally, Lenacapavir is currently under investigation for the prevention of HIV (PrEP) which is yet to be approved ...

A regulatory loophole allows manufacturers to add untested ingredients to food that are later found to be dangerous. Here’s ...

The drug is currently approved for treating heavily treatment-experienced (HTE) adults with multi-drug resistant HIV.